Trial Profile
An open-label study to examine the difference in tolerability associated with titration of dose on initiation of avonex [interferon beta-1a] therapy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2016
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms TODAY
- Sponsors Biogen
- 07 Jan 2008 New trial record.